Novel Biomarkers for Limb Girdle Muscular Dystrophy (LGMD)
Objective: To identify novel biomarkers as an alternative diagnostic tool for limb girdle muscular dystrophy (LGMD). Background: LGMD encompasses a group of muscular dystrophies characterized by proximal muscles weakness, elevated CK levels and dystrophic findings on muscle biopsy. Heterozygous <...
Main Authors: | Sara Aguti, Gian Nicola Gallus, Silvia Bianchi, Simona Salvatore, Anna Rubegni, Gianna Berti, Patrizia Formichi, Nicola De Stefano, Alessandro Malandrini, Diego Lopergolo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/4/329 |
Similar Items
-
Limb-girdle Muscular Dystrophy Type 2A with Mutation in CAPN3: The First Report in Taiwan
by: Chien-Hua Wang, et al.
Published: (2015-02-01) -
Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study
by: Amy Doody, et al.
Published: (2024-03-01) -
Novel mutations in the SGCA gene in unrelated Vietnamese patients with limb-girdle muscular dystrophies disease
by: Nam Chung Tran, et al.
Published: (2023-10-01) -
Limb Girdle Muscular Dystrophy due to Digenic Inheritance of DES and CAPN3 Mutations
by: Leema Reddy Peddareddygari, et al.
Published: (2018-09-01) -
Limb-girdle muscular dystrophy type 2B (LGMD2B) caused by pathogenic splice and missense variants of DYSF gene among Iranians with muscular dystrophy
by: Fatemeh Arab, et al.
Published: (2023-01-01)